Your account is not claimed yet. You can sign up with ORCID to claim your account.

Ji Hong Liu (Jihong Liu)

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 4

Top Topics

Randomized Controlled Trial

Vascular Endothelial Growth Factor

Endometrial Cancer

Top Venues

Journal of gynecologic oncology

Disease markers

Advances in therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Jun Guan, Yu Xue, Rong Yu Zang, Ji Hong Liu, Jian Qing Zhu, Ying Zheng, Bo Wang, Hua Ying Wang, Xiao-Jun Chen
Sentinel lymph Node mapping versus systematic pelvic lymphadenectomy on the prognosis for patients with intermediate-high-risk Endometrial Cancer confined to the uterus before surgery: trial protocol for a non-inferiority randomized controlled trial (SNEC trial). Journal of gynecologic oncology 32 (4) (2021)
Rong Jiang, Jian Qing Zhu, Jae-Weon Kim, Ji Hong Liu, Kazuyoshi Kato, Hee Seung Kim, Yuqin Zhang, Ping Zhang, Tao Zhu, Daisuke Aoki, Aijun Yu, Xiao-Jun Chen, Xipeng Wang, Ding Zhu, Wei Zhang, Huixun Jia, Ting Yan Shi, Wen Gao, Sheng Yin, Yanling Feng, Libing Xiang, Aikou Okamoto, Rong Yu Zang
Study of upfront surgery versus neoadjuvant chemotherapy followed by interval debulking surgery for patients with stage IIIC and IV ovarian cancer, SGOG SUNNY (SOC-2) trial concept. Journal of gynecologic oncology 31 (5) (2021)
Ting Wan, Hua Tu, Li-Li Liu, He Huang, Yanling Feng, Ji Hong Liu
Perineural Invasion Should Be Regarded as an Intermediate-Risk Factor for Recurrence in Surgically Treated Cervical Cancer: A Propensity Score Matching Study. Disease markers 2021 (2021)
Yanling Feng, He Huang, Ting Wan, Chuyao Zhang, Chongjie Tong, Ji Hong Liu
Comparison of PARPis with Angiogenesis Inhibitors and Chemotherapy for Maintenance in Ovarian Cancer: A Network Meta-Analysis. Advances in therapy 36 (12) (2019)